Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (KCT0011347) titled 'Clinical study on the effectiveness of Ukgan-san in patients with Hwa-byung with neurotic symptoms' on Dec. 18, 2025.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Kyung Hee University Industry-University Cooperation Foundation
Condition:
Codes for special purposes
Intervention:
Drug : 1. Investigational Product
- Product name: Eokgansan-Gajinpibanha Extract Granules
- Dosage form and appearance: Light brown granules
- Composition and amount per singl...